Details for Patent: 4,966,768
✉ Email this page to a colleague
Summary for Patent: 4,966,768
| Title: | Sustained release etodolac |
| Abstract: | A sustained release dosage form of etodolac is provided which is a tablet having as essential components etodolac, hydroxyproplymethylcellulose, ethylcellulose and a release rate modifying agent such as dibasic sodium phosphate, the hydroxyproplymethylcellulose having a hydroxypropoxyl content of about 7.0% to 8.6% by weight. |
| Inventor(s): | Michelucci; John J. (Plattsburgh, NY), Sherman; Deborah M. (Plattsburgh, NY), DeNeale; Richard J. (Willsboro, NY) |
| Assignee: | American Home Products Corporation (New York, NY) |
| Application Number: | 07/268,646 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Compound; Dosage form; |
Drugs Protected by US Patent 4,966,768
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 4,966,768
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 62132 | ⤷ Try a Trial | |||
| Australia | 2215388 | ⤷ Try a Trial | |||
| Australia | 613663 | ⤷ Try a Trial | |||
| Bulgaria | 60697 | ⤷ Try a Trial | |||
| Canada | 1318600 | ⤷ Try a Trial | |||
| Germany | 3862272 | ⤷ Try a Trial | |||
| Denmark | 168421 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
